POINT72 ASSET MANAGEMENT, L.P. Relmada Therapeutics, Inc. Transaction History

POINT72 ASSET MANAGEMENT, L.P. portfolio value:

$2.59M
portfolio value

Relmada Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -34.21% -435.38K shares 6.82M $37.02 837.19K
Q3 2022 call Increase 0.00% 70K shares 2.59M $37.02 70K
Q2 2022 share Decrease -3.03% -39.82K shares -11.25M $18.99 1.27M
Q1 2022 share Increase +38.69% 366.08K shares 14.10M $26.99 1.31M
Q4 2021 share Increase +330.14% 726.31K shares 15.55M $21.71 946.31K
Q3 2021 share Increase +13.10% 25.49K shares -460K $26.21 220K
Q2 2021 share Increase +12.76% 22.01K shares 152K $32.01 194.51K
Q1 2021 share Decrease -39.47% -112.5K shares -3.06M $35.21 172.5K
Q4 2020 share Increase +43.01% 85.70K shares 1.64M $32.07 285K
Q3 2020 share Increase +21.11% 34.73K shares 133K $37.62 199.29K
Q2 2020 share Increase 0.00% 164.55K shares 7.36M $44.75 164.55K
Q1 2020 share Decrease -100.00% -136.9K shares -5.33M $34.11 0
Q4 2019 share Increase 0.00% 136.9K shares 5.33M $39 136.9K